by Brandon Tudor | Nov 6, 2025 | Uncategorized
Brandon Tudor, Dr. Al Lalos and Pete Celano of LiverRight hope to see you this week in DC at the AASLD meeting. What’s the most prevalent yet undiagnosed specialty condition, that is VERY straightforward to diagnose and treat, and its early stages (F1 and F2)...
by Brandon Tudor | Nov 2, 2025 | Uncategorized
Here’s a detailed summary of “Entering Our Fourth Decade: The Next Chapter of Liver Transplantation” by Andrés Cárdenas and Timuçin Taner, dated October 28, 2025. Overview This editorial marks the beginning of the authors’ tenure as Editors-in-Chief of Liver...
by Brandon Tudor | Oct 28, 2025 | Uncategorized
The November 2025 article published in The Journal of Hepatology and titled “Non-invasive tests for MetALD and alcohol-related liver disease” is summarized in what follows, and makes these key points– — Non-invasive tests are available and...
by Brandon Tudor | Oct 24, 2025 | Uncategorized
Here’s a concise summary of the article “Low awareness of Metabolic dysfunction–associated steatotic liver disease (MASLD) among U.S. adults: Trends from National Health and Nutrition Examination Survey (NHANES) 2017–2023” by Alp et al., Hepatology Communications...
by Brandon Tudor | Oct 20, 2025 | Uncategorized
The VA continues to innovate in healthcare generally and liver disease specifically. Including with GLP-1s–“GLP1-RA reduces risk of death in liver disease patients Researchers from VA Orlando and the University of Florida reported Veterans with...
